Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -105.87M | -74.15% | $ 142.77M |
3/31/2025 | $ 500K | 0.25% | $ 197.5M |
12/31/2024 | $ -20.44M | -7.66% | $ 266.96M |
9/30/2024 | $ -61.98M | -20.37% | $ 304.34M |
6/30/2024 | $ -54.27M | -17.61% | $ 308.13M |
3/31/2024 | $ -152.92M | -50.66% | $ 301.87M |
12/31/2023 | $ -174.88M | -67.98% | $ 257.24M |
9/30/2023 | $ -261.9M | -124.08% | $ 211.07M |
6/30/2023 | $ -244.69M | -134.5% | $ 181.93M |
3/31/2023 | $ -255.81M | -139.51% | $ 183.36M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for COHERUS ONCOLOGY INC is calculated as follows: CF - Operations [ $ 138.73M ] / Revenues [ $ 489.26M ]
(=) OCF % [ 28.36% ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |